Pairing 3D-Printing with Nanotechnology to Manage Metabolic Syndrome

INTRODUCTION: This work was aimed to develop a Curcuma oil-based self-nanoemulsifying drug delivery system (SNEDDS) 3D-printed polypills containing glimepiride (GMD) and rosuvastatin (RSV) for treatment of dyslipidemia in patients with diabetes as a model for metabolic syndrome (MS). METHODS: Compar...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Say, Khalid M, Felimban, Raed I, Tayeb, Hossam H, Chaudhary, Adeel G, Omar, Abdelsattar M, Rizg, Waleed Y, Alnadwi, Fuad H, Abd-Allah, Fathy I, Ahmed, Tarek A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038162/
https://www.ncbi.nlm.nih.gov/pubmed/35479768
http://dx.doi.org/10.2147/IJN.S357356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038162/
https://www.ncbi.nlm.nih.gov/pubmed/35479768
http://dx.doi.org/10.2147/IJN.S357356

Ejemplares similares